VU University Medical Center
Scheltens has long-lasting research experience in the field of magnetic resonance imaging and biomarkers in dementia with respect to early diagnosis and monitoring of treatment. Experience in leading clinical trials from phase 1 to 3, in a multicentre setting. Most relevant current experience is being PI of the Souvenir study with medical food in mild drug naïve AD patients, placebo-controlled, for 3-6 months. This qualification adds nicely to the other clinical centres involved.